Program

12
1

Journal Year Published

1
3
2
1
1
1
1
1
1
1

Author

13
202
181
149
140
133
133
125
123
108
105
95
82
78
64
63
55
50
46
43
43

Category

6
5
2
2
2
1
1

Keyword

5
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1

Journal

2
1
1
1
1
1
1
1
1
1
1
1

NCATS Publications

A Combinatorial Strategy for Targeting BRAFV600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).


Ghosh C, Kumar S, Kushchayeva Y, Gaskins K, Boufraqech M, Wei D, Gara SK, Zhang L, Zhang Y, Shen M, Mukherjee S, Kebebew E


Clin. Cancer Res. , (26), 2022-2036, 2020.

Article Pubmed

Sample image from publication page

Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.


Kearney SE, et al.


ACS Cent Sci , (4), 1727-1741, 2018.

Article Pubmed

Sample image from publication page

Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.


Shen M, Asawa R, Zhang Y, Cunningham E, Sun H, Tropsha A, Janzen WP, Muratov EN, Capuzzi SJ, Farag S, Jadhav A, Blatt J, Simeonov A, Martinez N


Oncotarget , (9), 4758-4772, 2018.

Article Pubmed

Sample image from publication page

Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors.


Singh A, Venkannagari S, Oh KH, Zhang Y, Liu L, Rohde JM, Nimmagadda S, Sudini K, Brimacombe K, Gajghate S, Ma J, Wang A, Xu X, Shahane SA, Xia M, Woo J, A Mensah G, Wang Z, Ferrer-Alegre M, Gabrielson E, Li Z, Rastinejad F, Shen M, Boxer MB, Biswal S


ACS Chem. Biol. , 2016.

Article Pubmed

A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics.


Tschapalda K, Zhang Y, Liu L, Golovnina K, Schlemper T, Eichmann TO, Lal-Nag M, Sreenivasan U, McLenithan J, Ziegler S, Sztalryd C, Lass A, Auld D, Oliver B, Waldmann H, Li Z, Shen M, Boxer MB, Beller M


EBioMedicine , (8), 49-59, 2016.

Article Pubmed

Sample image from publication page

TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.


Jain M, Zhang L, He M, Zhang Y, Shen M, Kebebew E


Endocr. Relat. Cancer , (20), 361-70, 2013.

Article Pubmed

Sample image from publication page